← Back to Search

Group Education for Cancer Screening

N/A

Waitlist Available

Led By Jose Rauh-Hain, MD,MPH

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Arm 1: Diagnosis of MDS intermediate/high/very high risk by Revised International Prognostic Scoring System (IPSS-R), Untreated or up to 2 prior treatments

Arm 2: Diagnosis of relapsed/refractory AML (per European Leukemia Network 2022) receiving treatment as salvage 1-2

Must not have

Patients with any other known concurrent severe and/or uncontrolled medical condition

Prior organ transplantation within 3 months prior to planned enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion; an average of 1 year.

Awards & highlights

Summary

This trial aims to see if group education sessions can help medically underserved women and minorities with BRCA 1 and 2 mutations to better follow recommended screening and risk-reducing procedures.

Who is the study for?

This trial is for medically underserved women and racial/ethnic minorities who have BRCA 1 or 2 gene mutations, which are linked to a higher risk of cancer. Participants should be interested in learning about surveillance and procedures to reduce their cancer risk.

What is being tested?

The study is testing an educational program delivered through group sessions. The goal is to see if this intervention can help participants follow recommended health screenings and preventive measures more closely.

What are the potential side effects?

Since the interventions involve education content and focus groups, there aren't any direct medical side effects. However, discussing sensitive topics like cancer risks may cause emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My MDS is intermediate/high/very high risk and I've had 0-2 treatments.

Select...

I have AML that has come back or didn't respond to treatment, and I'm on my first or second attempt at salvage therapy.

Select...

I am 18 years old or older.

Select...

I can take care of myself but might not be able to do heavy physical work.

Select...

I am following the required birth control measures or am unable to have children.

Select...

I am a male following the required guidelines for contraception or am sterile.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have any severe or uncontrolled medical conditions.

Select...

I had an organ transplant less than 3 months ago.

Select...

My leukemia affects my brain and is not well-managed.

Select...

My condition is currently active and not under control.

Select...

I am currently receiving cancer treatment for another cancer.

Select...

I have HIV that is not currently under control.

Select...

I have not had major surgery in the last 14 days.

Select...

I do not have any severe or poorly controlled health conditions.

Select...

I need to take anti-TNF drugs.

Select...

I have not received a live vaccine in the last 28 days.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion; an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion; an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Safety and Adverse Events (AEs)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard of CareExperimental Treatment1 Intervention

Participants will be randomized into one of two arms through REDCap

Group II: ACT-Together InterventionExperimental Treatment1 Intervention

Participants will be randomized into one of two arms through REDCap

0 / 16Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

3,039 Previous Clinical Trials

1,799,686 Total Patients Enrolled

Jose Rauh-Hain, MD,MPHPrincipal InvestigatorM.D. Anderson Cancer Center

1 Previous Clinical Trials

80 Total Patients Enrolled

~10 spots leftby Dec 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.